1. Home
  2. PHR vs NPCE Comparison

PHR vs NPCE Comparison

Compare PHR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$9.67

Market Cap

583.9M

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.97

Market Cap

576.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHR
NPCE
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
583.9M
576.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PHR
NPCE
Price
$9.67
$15.97
Analyst Decision
Buy
Strong Buy
Analyst Count
18
6
Target Price
$21.18
$18.33
AVG Volume (30 Days)
1.6M
190.8K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
103.92
29.03
EPS
0.05
N/A
Revenue
$480,591,000.00
$99,986,000.00
Revenue This Year
$8.43
$0.90
Revenue Next Year
$5.10
$24.46
P/E Ratio
$207.20
N/A
Revenue Growth
14.48
25.13
52 Week Low
$7.77
$7.56
52 Week High
$32.76
$19.60

Technical Indicators

Market Signals
Indicator
PHR
NPCE
Relative Strength Index (RSI) 51.93 45.85
Support Level $8.00 $15.40
Resistance Level $10.27 $16.96
Average True Range (ATR) 0.60 0.77
MACD 0.14 -0.09
Stochastic Oscillator 49.61 35.42

Price Performance

Historical Comparison
PHR
NPCE

About PHR Phreesia Inc.

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: